Follow the Milestone Pharmaceuticals Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Health Care sector, Milestone Pharmaceuticals Inc. has recorded 10 insider filings. Market capitalisation: €178.9m. The latest transaction was reported on 15 July 2025 (Attribution). Among the most active insiders: Bharucha David. All data is openly available.
10
Insider Decl.
0
Thresholds
€14m
6 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Milestone Pharmaceuticals Inc. Strong Buy (bullish), based on 6 analysts. Average price target: US$6.33.
41Σ signal
Buys €14m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.